Gastric infection by Helicobacter pylori
- PMID: 19903421
- PMCID: PMC4492511
- DOI: 10.1007/s11894-009-0070-y
Gastric infection by Helicobacter pylori
Abstract
Helicobacter pylori infection causes chronic active gastritis, ulcer disease, and gastric cancer. Current eradication regimens use a proton pump inhibitor (PPI) and two antibiotics. Triple therapy now has a success rate less than 80%, below the cutoff for efficacious eradication. Antibiotic resistance, inconsistent acid control by PPIs, and poor patient compliance contribute to the failure rate. H. pylori is a neutralophile that has developed special acid acclimation mechanisms to colonize its acidic gastric niche. Identifying the components of these mechanisms will provide novel bactericidal drug targets. Alternatively, better 24-hour acid control would increase the efficacy of antibiotics, leading to dual therapy with improved PPIs and amoxicillin. Studies of acid acclimation by H. pylori have identified several potential eradication targets including UreI, alpha-carbonic anhydrase, and a two-component system. Continuing improvement of PPIs has led to the development of at least three candidate drugs with improved 24-hour acid control.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Figures

Similar articles
-
Gastric infection by Helicobacter pylori.Curr Gastroenterol Rep. 2011 Dec;13(6):540-6. doi: 10.1007/s11894-011-0226-4. Curr Gastroenterol Rep. 2011. PMID: 21993716 Free PMC article. Review.
-
'Rescue' therapies for the management of Helicobacter pylori infection.Dig Dis. 2006;24(1-2):113-30. doi: 10.1159/000090315. Dig Dis. 2006. PMID: 16699270 Review.
-
[Helicobacter pylori, a rediscovered bacterium. Implication in gastroduodenal diseases].Presse Med. 1995 Jan 14;24(2):67-73, 75-6, 78-9. Presse Med. 1995. PMID: 7899350 Review. French.
-
High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.Medicine (Baltimore). 2016 Oct;95(42):e4410. doi: 10.1097/MD.0000000000004410. Medicine (Baltimore). 2016. PMID: 27759625 Free PMC article. Clinical Trial.
-
No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.Aliment Pharmacol Ther. 1995;9 Suppl 1:39-42. doi: 10.1111/j.1365-2036.1995.tb00782.x. Aliment Pharmacol Ther. 1995. PMID: 7495941 Review.
Cited by
-
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.Osteoporos Int. 2011 Mar;22(3):903-10. doi: 10.1007/s00198-010-1337-8. Epub 2010 Jun 29. Osteoporos Int. 2011. PMID: 20585937 Free PMC article.
-
Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases.World J Gastroenterol. 2016 Nov 28;22(44):9718-9726. doi: 10.3748/wjg.v22.i44.9718. World J Gastroenterol. 2016. PMID: 27956795 Free PMC article. Review.
-
Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.Clin Vaccine Immunol. 2011 Nov;18(11):1957-61. doi: 10.1128/CVI.05306-11. Epub 2011 Sep 7. Clin Vaccine Immunol. 2011. PMID: 21900527 Free PMC article.
-
Protein-Loosing Entropathy Induced by Unique Combination of CMV and HP in an Immunocompetent Patient.Case Rep Med. 2012;2012:361892. doi: 10.1155/2012/361892. Epub 2012 Nov 8. Case Rep Med. 2012. PMID: 23197985 Free PMC article.
-
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.Helicobacter. 2014 Aug;19(4):319-22. doi: 10.1111/hel.12126. Epub 2014 Apr 3. Helicobacter. 2014. PMID: 24698653 Free PMC article. Clinical Trial.
References
-
- Akre K, Signorello LB, Engstrand L, et al. Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement. Cancer Res. 2000;60:6376–6380. - PubMed
-
- Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789. - PubMed
-
- Loffeld RJ, Werdmuller BF, Kuster JG, et al. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett’s esophagus. Digestion. 2000;62:95–99. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical